Compounds > n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and pomalidomide

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with pomalidomide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brady, H; Chan, K; Corral, LG; De Parseval, LM; Ferguson, GD; Jensen-Pergakes, K; Jhaveri, U; Morris, CL; Richard, N; Verhelle, D; Wilkey, C; Xie, W	1

Other Studies

1 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and pomalidomide

Article	Year
Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2. Journal of clinical immunology, 2007, Volume: 27, Issue:2 Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Synergism; Gene Expression; Humans; Immunologic Factors; Immunoprecipitation; Lipopolysaccharides; Membrane Proteins; Monocytes; Nitrobenzenes; Prostaglandins; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thalidomide; Transcription, Genetic	2007

Article

Year

Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2.

Journal of clinical immunology, 2007, Volume: 27, Issue:2

Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Synergism; Gene Expression; Humans; Immunologic Factors; Immunoprecipitation; Lipopolysaccharides; Membrane Proteins; Monocytes; Nitrobenzenes; Prostaglandins; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thalidomide; Transcription, Genetic

2007